-
1
-
-
0035174504
-
Phase I chemoprevention clinical trial of curcumin, a chemopreventive agent, in patients with high risk or pre-malignant lesions
-
Cheng A.L., Lin J.K., Hsu M.M., Lin J.T., Hsu M.M., Ho Y.F., Shen T.S., Ko J.Y., Lin J.T., Lin B.R., Wu M.S., Yu H.S., Jee S.H., Chen G.S., Chen T.M., Chen C.A., Lai M.K., Pu Y.S., Pan M.H., Wang U.J., Tsai C.C., Hsieh C.Y. Phase I chemoprevention clinical trial of curcumin, a chemopreventive agent, in patients with high risk or pre-malignant lesions. Anticancer Res. 21:2001;2895-2900.
-
(2001)
Anticancer Res.
, vol.21
, pp. 2895-2900
-
-
Cheng, A.L.1
Lin, J.K.2
Hsu, M.M.3
Lin, J.T.4
Hsu, M.M.5
Ho, Y.F.6
Shen, T.S.7
Ko, J.Y.8
Lin, J.T.9
Lin, B.R.10
Wu, M.S.11
Yu, H.S.12
Jee, S.H.13
Chen, G.S.14
Chen, T.M.15
Chen, C.A.16
Lai, M.K.17
Pu, Y.S.18
Pan, M.H.19
Wang, U.J.20
Tsai, C.C.21
Hsieh, C.Y.22
more..
-
2
-
-
1142291226
-
-
U.S. Pat. Appl. 2003/0153512 A1
-
Hergenhahn, M., Bertram, B., Wiessler, M., Sorg, B.L., 2003. Curcumin derivatives with improved water solubility compared to curcumin and medicaments containing the same. U.S. Pat. Appl. 2003/0153512 A1.
-
(2003)
Curcumin Derivatives with Improved Water Solubility Compared to Curcumin and Medicaments Containing the Same
-
-
Hergenhahn, M.1
Bertram, B.2
Wiessler, M.3
Sorg, B.L.4
-
3
-
-
0003822811
-
-
International Book Distributors, Dehradun 4
-
Kirtikar, K.R., Basu, B.D., 1987. Indian Medicinal Plants, 2nd ed. International Book Distributors, Dehradun 4, pp. 2423-2426.
-
(1987)
Indian Medicinal Plants, 2nd Ed.
, pp. 2423-2426
-
-
Kirtikar, K.R.1
Basu, B.D.2
-
5
-
-
0033663452
-
Physical stabilisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25
-
Mooter G.V., Wuyts M., Blaton N., Busson R., Grobet P., Augustijns P., Kinget R. Physical stabilisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25. Eur. J. Pharm. Sci. 12:2001;261-269.
-
(2001)
Eur. J. Pharm. Sci.
, vol.12
, pp. 261-269
-
-
Mooter, G.V.1
Wuyts, M.2
Blaton, N.3
Busson, R.4
Grobet, P.5
Augustijns, P.6
Kinget, R.7
-
6
-
-
0018873182
-
Absorption and tissue distribution of curcumin in rats
-
Ravindranath V., Chandrasekhara N. Absorption and tissue distribution of curcumin in rats. Toxicology. 16:1980;259-265.
-
(1980)
Toxicology
, vol.16
, pp. 259-265
-
-
Ravindranath, V.1
Chandrasekhara, N.2
-
8
-
-
0031472539
-
Turmeric: A brief review of medicinal properties
-
Srimal R.C. Turmeric: a brief review of medicinal properties. Fitoterapia. 68:1997;483-493.
-
(1997)
Fitoterapia
, vol.68
, pp. 483-493
-
-
Srimal, R.C.1
-
9
-
-
85030900551
-
-
Patentschrift DE 40 26 118 C2
-
Todd, P.H., 1991. Curcumin-Komplexe. Patentschrift DE 40 26 118 C2.
-
(1991)
Curcumin-Komplexe
-
-
Todd, P.H.1
-
10
-
-
0020622781
-
High performance liquid chromatography of curcumin and related compounds
-
Tonnesen H.H., Karlsen J. High performance liquid chromatography of curcumin and related compounds. J. Chromatogr. 259:1983;367-371.
-
(1983)
J. Chromatogr.
, vol.259
, pp. 367-371
-
-
Tonnesen, H.H.1
Karlsen, J.2
-
11
-
-
0022066944
-
Studies on curcumin and curcuminoids. VI. Kinetics of curcumin degradation in aqueous solution
-
Tonnesen H.H., Karlsen J. Studies on curcumin and curcuminoids. VI. Kinetics of curcumin degradation in aqueous solution. Z. Lebensm. Unters. Forsch. 180:1985;402-404.
-
(1985)
Z. Lebensm. Unters. Forsch.
, vol.180
, pp. 402-404
-
-
Tonnesen, H.H.1
Karlsen, J.2
-
12
-
-
0037026270
-
Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: Solubility, chemical and photochemical stability
-
Tonnesen H.H., Masson M., Loftsson T. Studies of curcumin and curcuminoids. XXVII. Cyclodextrin complexation: solubility, chemical and photochemical stability. Int. J. Pharm. 244:2002;127-135.
-
(2002)
Int. J. Pharm.
, vol.244
, pp. 127-135
-
-
Tonnesen, H.H.1
Masson, M.2
Loftsson, T.3
-
13
-
-
0030839940
-
Stability of curcumin in buffer solutions and characterization of its degradation products
-
Wang Y.J., Pan M.H., Cheng A.L., Lin L.I., Ho Y.S., Hsieh C.Y., Lin J.K. Stability of curcumin in buffer solutions and characterization of its degradation products. J. Pharm. Biomed. Anal. 15:1997;1867-1876.
-
(1997)
J. Pharm. Biomed. Anal.
, vol.15
, pp. 1867-1876
-
-
Wang, Y.J.1
Pan, M.H.2
Cheng, A.L.3
Lin, L.I.4
Ho, Y.S.5
Hsieh, C.Y.6
Lin, J.K.7
|